Niosome as a drug carrier for topical delivery of N-acetyl glucosamine

Research in Pharmaceutical Sciences

Volumn 5, Issue 2, 2010, Pages 107-117

  Shatalebi, M A ^a   Mostafavi, S A ^a   Moghaddas, A ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HPLC; N acetyl glucosamine; Noisome; Topical delivery

Indexed keywords

N ACETYLGLUCOSAMINE; NIOSOME; SORBITAN PALMITATE; SORBITAN STEARATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICROSCOPY; NONHUMAN; PARTICLE SIZE; RAT; SCANNING ELECTRON MICROSCOPY; SKIN; SKIN PENETRATION;

EID: 79953212584     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Couvreur P, Fattal E, Andremont A. Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm Res. 1991;8:1079-1086.
2. Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Rel. 1994;30:1-15. (Pubitemid 24173173)
3. Uchegbu IF, Vyas SP. Non-Ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33-70. (Pubitemid 28430243)
4. Bandak S, Ramu A, Barenholz Y. Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated leptosomes. Pham Res. 1999;16:841-846. (Pubitemid 29284194)
5. Tsuchihashi M, Harashima H, Kiwada H. Development of pharmacokinetic/ pharmacodynamic (PK/PD)- simulation system for doxorubicin in long circulating leptosomes in mice using peritoneal. J control Rel. 1999;61:9-19. (Pubitemid 29406076)
6. laure AC, Ramachandran C, Lieb LM. Targeted delivery to the pilosebaceous unit via leptosomes. Adv Drug Deliv. 1996;18:311-324.
7. Manosroi A, Wongtrakul P, Manosroi J, Saka H, Sugaware F, Yuasa M, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B: Biointerfaces. 2003;30:129-138. (Pubitemid 36623337)
8. Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs. 1994,31:81-86. (Pubitemid 24176565)
9. Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and sorbitan triester (Span 85). Int J Pharm. 1994;105:1-6.
10. Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Rel. 1998;54:149-165. (Pubitemid 28342694)
11. Weindl G, Schaller M, Schafer-korting M, Korting HC. Hyaluronic acid in the treatment and prevention of skin diseases. Molecular, biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol. 2004;17:207-213.
12. Sayo T, Sakais I. Synergistic effect of N-acetyl glucoseamine and retinoids on hydaluronan production in human keration cytes. Skin Pharmacol Physiol. 2004;17:77-83. (Pubitemid 38250514)
13. Ghersetich I, Lotti T, Campanile G, Grappone C, Dini G. Hyaluronic acid in cutaneous aging. Int J Dermatol. 1994;33:119-122.
14. Imokawa G. Analysis of carbohydrate properties essential for melanogenesis in tyrosinase of cultured malignant melanoma cells by differential carbohydrate processing inhibition. J Invest Dermatol. 1990;958:39-49. (Pubitemid 20219441)
15. Imokawa G. Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione. J Invest Dermatol. 1989;93:101-107.
16. Imokawa G, Mishima Y. Importance of glycolproteins in the initiation of melanogenesisi an electron microscopie study of B-16 melanoma cells after release from inhibition of glycosylation. J Invest Dermatol. 1986;87:319-325. (Pubitemid 16051169)
17. Imokawa G, Mishima Y. Analysis of tyrosinases as asparagines linked oligosaccharides by concanvalin a lectin chromatography: appearance of new segment of tyrosinase in melanoma cells following interrupted melanogenesis induced by glycosylation inhibitors. J Invest Dermatol. 1985;85:165-168. (Pubitemid 15007105)
18. Imokawa G, Mishima Y. Functional analysis of tyrosinase isoanzymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenosis induced by glycosylation inhibitors. J Invest Dermatol. 1984;83:196-201. (Pubitemid 14063908)
19. Mishima Y, Imokawa G. Selective aberration and pigment loss in melanosomes of malignant melanoma cells in vitro by glycosylation inhibitors: premelano-somes as glycoprotien. J Invest Dermatol. 1983;81:106-114. (Pubitemid 13026312)
20. Imokawa G, Mishima Y. Loss of melanogenic properties in tyrosinases induced by glycosylation inhibitors within malignant melanoma cells. Cancer Res. 1982;42:1994-2002. (Pubitemid 12103404)
21. Bissett DL, Mcphail SJ, farmer TL, Robinson MK, Tiesman JP, Reichling TD. Topical N-acetyl glucosamine effects pigmentation-relevant genes in vitro genomics testing. Pig cell Res. 2006;19:373.
22. Bissett Dl, Robinson L, Li J, Miyamoto K. Topical N-acetyl glucosamine reduces the appearance of hyper pigmented spots on human facial skin. J Am Acad Dermatol. 2006;54:AB54.
23. Kanwischer M, Kim SY, Kim JS, Bian S, Kwon KA, Kim DD. Evaluation of the physicochemical stability and skin permeation of glucosamine sulfate. Drug Dev Ind Pharm. 2005;31:91-97. (Pubitemid 40170590)
24. Martindale: The complete drug reference. 34th ed. London: Pharmaceutical Press; 2005.
25. Colmbo P, Bettini PR, Brazel CS, Peppas NA. Drug Release from swelling-controlled system. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker; 2000. p. 183-209.
26. Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm. 2006;323:1-10
27. Fang JK, hung YB, Tsai YH. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pham. 2001;215:91-99.
28. Montenegro L, Panico AM, Ventimiglia A, Bonina, FP. In vitro retinoic acid release and skin permeation from different liposome formulations. Int J Pharm. 1996;133:89-96.
29. Bernard E, Dubios JL, Wepierre J. Importance of sebaceous glands in cutaneous penetration of an ant androgen: target effect of liposomes. J Pharm Sci. 1997;86:573-578. (Pubitemid 27203404)